Paul Stoffels

• Chief Scientific Officer and Worldwide Chairman, Pharmaceuticals, Johnson & Johnson, USA

Studies in Medicine, Univ. of Diepenbeek and Univ. of Antwerp, Belgium, and Infectious Diseases and Tropical Medicine, Institute of Tropical Medicine, Antwerp, Belgium. Former: Physician, Africa; CEO, Virco; Chairman, Tibotec, leading the development of PREZISTA and INTELENCE, for the treatment of HIV. With Johnson & Johnson: 2006-09, Company Group Chairman; from 2009, Global Head, Johnson & Johnson Pharmaceutical R&D; currently, Chief Scientific Officer; Member, Exec. Cttee and Management Cttee; chairs the Worldwide Research & Development Council; provides oversight to the Johnson & Johnson Development Corporation (JJDC) and the Johnson & Johnson innovation centres; Worldwide Chairman, Pharmaceuticals.